TIMI 11B Study Design
Enoxaparin
30 mg IV bolus +
1.0 mg/kg q 12 H
subcutaneous
Heparin
70 U/kg IV bolus +
15U/Kg/h UFH
IV
Unstable Angina
Non-Q Wave MI
Acute Phase
min 72H, max 8 Days
Chronic Phase
Fixed Dose
< 65 kg > 65 kg
40 mg 60 mg
q 12 H
43 days
Antman EM, et al. Circulation 1999;100:1593-1601.
Fixed Dose
placebo
q 12 H
Previous slide
Next slide
Back to first slide
View graphic version